# REGN5381 in Adult Participants With Uncontrolled Hypertension

> **NCT06833190** · PHASE2 · TERMINATED · sponsor: **Regeneron Pharmaceuticals** · enrollment: 34 (actual)

## Conditions studied

- Uncontrolled Hypertension

## Interventions

- **DRUG:** REGN5381
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06833190
- **Lead sponsor:** Regeneron Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2025-04-16
- **Primary completion:** 2025-10-15
- **Final completion:** 2025-10-15
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2025-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06833190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06833190, "REGN5381 in Adult Participants With Uncontrolled Hypertension". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT06833190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*